FGF1 and diabetes mellitus: A previous study showed that the protective effect of exogenous administration with FGF1 is dependent on RAGE (Zheng et al., 2021); thus, inhibition of RAGE might be able to mimic the protective phenotype of FGF1 in diabetes.